{"id":380717,"date":"2026-04-10T14:00:22","date_gmt":"2026-04-10T08:30:22","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=380717"},"modified":"2026-04-10T14:19:37","modified_gmt":"2026-04-10T08:49:37","slug":"cam-advises-healthcare-global-rights-issue-424-crore","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/","title":{"rendered":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Cyril Amarchand Mangaldas (&#8220;<span style=\"font-weight: bold;\">CAM<\/span>&#8220;) advised Healthcare Global Enterprises Limited on their rights issue of equity shares. The deal size was INR 42,468.18 lakhs approx. The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on April 1, 2026.<\/p>\n<p style=\"margin-bottom: 3%;\">The CAM team offered in-depth counsel to Healthcare Global Enterprises on all significant aspects of the rights issue.<\/p>\n<p style=\"margin-bottom: 3%;\">The transaction team was led by <span style=\"font-weight: bold;\">Yash Ashar<\/span>, Senior Partner; <span style=\"font-weight: bold;\">Reuben Chacko<\/span>, <span style=\"font-style: italic;\">Partner (Regional Co-Head &#8211; Capital Markets &#8211; South);<\/span> and <span style=\"font-weight: bold;\">Abhyuday Bhotika<\/span>, <span style=\"font-style: italic;\">Partner;<\/span> with support from <span style=\"font-weight: bold;\">Surya Rajkumar, Bhaskar Kumar, Dhruv Sharma<\/span>, and <span style=\"font-weight: bold;\">Megha Rajesh<\/span>, <span style=\"font-style: italic;\">Associates<\/span>.<\/p>\n<p style=\"margin-bottom: 3%;\"><span style=\"font-weight: bold;\">Anand Jayachandran<\/span>, <span style=\"font-style: italic;\">Partner;<\/span> along with <span style=\"font-weight: bold;\">Astha Tambi<\/span>, <span style=\"font-style: italic;\">Principal Associate;<\/span> and <span style=\"font-weight: bold;\">Arundhati Diljit<\/span>, <span style=\"font-style: italic;\">Associate;<\/span> advised on certain arrangements in connection with participation of promoters in the right issue.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">The shares commenced trading on BSE and NSE on April 1, 2026, with the firm providing comprehensive legal advisory across all aspects of the capital raising transaction.<\/p>\n","protected":false},"author":67011,"featured_media":380732,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[68835,30960,102147,102146,102148,102149],"class_list":["post-380717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-cam","tag-cyril-amarchand-mangaldas","tag-hcg-rights-issue","tag-healthcare-global","tag-healthcare-sector-fundraising","tag-promoter-participation-rights-issue"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.4 (Yoast SEO v26.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares | SCC Times<\/title>\n<meta name=\"description\" content=\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\" \/>\n<meta property=\"og:description\" content=\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T08:30:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-10T08:49:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/\",\"name\":\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares | SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp\",\"datePublished\":\"2026-04-10T08:30:22+00:00\",\"dateModified\":\"2026-04-10T08:49:37+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp\",\"width\":886,\"height\":590,\"caption\":\"CAM Advises HCG Rights Issue\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares | SCC Times","description":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/","og_locale":"en_US","og_type":"article","og_title":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares","og_description":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares","og_url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2026-04-10T08:30:22+00:00","article_modified_time":"2026-04-10T08:49:37+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/","url":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/","name":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp","datePublished":"2026-04-10T08:30:22+00:00","dateModified":"2026-04-10T08:49:37+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp","width":886,"height":590,"caption":"CAM Advises HCG Rights Issue"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/04\/10\/cam-advises-healthcare-global-rights-issue-424-crore\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Cyril Amarchand Mangaldas advised Healthcare Global Enterprises Limited on their rights issue of equity shares"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/04\/CAM-Advises-HCG-Rights-Issue.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":348430,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/05\/21\/fusion-finance-rights-issue-cam-advises\/","url_meta":{"origin":380717,"position":0},"title":"Cyril Amarchand Mangaldas advises Fusion Finance on rights issue of partly paid-up equity shares","author":"Editor","date":"May 21, 2025","format":false,"excerpt":"Cyril Amarchand Mangaldas advised Fusion Finance on its rights issue of partly paid-up equity shares","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Fusion Finance rights issue","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/shared-image-92.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/shared-image-92.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/shared-image-92.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/05\/shared-image-92.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":355958,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/08\/07\/cyril-amarchand-advices-astec-lifesciences-rights-issue\/","url_meta":{"origin":380717,"position":1},"title":"Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares","author":"Editor","date":"August 7, 2025","format":false,"excerpt":"The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on July 31, 2025.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Astec LifeSciences rights issue","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/08\/Astec-LifeSciences-rights-issue.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":328569,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/08\/13\/cyril-amarchand-mangaldas-advises-sobha-limited-in-its-rights-issuance-of-partly-paid-up-equity-shares-aggregating-to-19990-28-million\/","url_meta":{"origin":380717,"position":2},"title":"Cyril Amarchand Mangaldas advises Sobha Limited in its rights issuance of partly paid-up equity shares aggregating to around \u20b919,000 million","author":"Bhumika Indulia","date":"August 13, 2024","format":false,"excerpt":"CAM played crucial role, provided comprehensive legal counsel and strategic guidance to ensure the successful execution of the transaction.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Cyril Amarchand Mangaldas","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/cyril-35.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/cyril-35.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/cyril-35.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/08\/cyril-35.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":370571,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/22\/cyril-amarchand-mangaldas-advises-adani-enterprises-rights-issue-2025\/","url_meta":{"origin":380717,"position":3},"title":"Cyril Amarchand Mangaldas Advises Adani Enterprises on \u20b924,930 Crores Rights Issue","author":"Editor","date":"December 22, 2025","format":false,"excerpt":"The transaction was undertaken in compliance with SEBI ICDR Regulations and marks one of the largest rights issues in the Indian capital markets.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises Adani Enterprises","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-Adani-Enterprises.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-Adani-Enterprises.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-Adani-Enterprises.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-Adani-Enterprises.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":370347,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/20\/cyril-amarchand-mangaldas-advises-ifc-nephrocare-health-services-ipo\/","url_meta":{"origin":380717,"position":4},"title":"Cyril Amarchand Mangaldas Advises IFC on Nephrocare Health Services Limited IPO","author":"Editor","date":"December 20, 2025","format":false,"excerpt":"The IPO comprised a fresh issue and an offer for sale, with IFC divesting part of its shareholding. Nephrocare\u2019s equity shares were listed on Indian stock exchanges on 17 December 2025.","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"CAM Advises IFC Nephrocare","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/CAM-Advises-IFC-Nephrocare.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":330714,"url":"https:\/\/www.scconline.com\/blog\/post\/2024\/09\/13\/cyril-amarchand-mangaldas-acts-as-legal-counsel-to-brigade-enterprises-limited-on-the-issuance-of-equity-shares-by-way-of-qip\/","url_meta":{"origin":380717,"position":5},"title":"Cyril Amarchand Mangaldas acts as legal counsel to Brigade Enterprises Limited on the issuance of equity shares by way of QIP","author":"Bhumika Indulia","date":"September 13, 2024","format":false,"excerpt":"Cyril Amarchand Mangaldas (CAM) advised Brigade Enterprises Limited (\u201cBrigade\u201d) as its legal counsel on the issuance of equity shares","rel":"","context":"In &quot;Law Firms News&quot;","block_context":{"text":"Law Firms News","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/law-firms-news\/"},"img":{"alt_text":"Brigade Enterprises Limited","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Brigade-Enterprises-Limited.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Brigade-Enterprises-Limited.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Brigade-Enterprises-Limited.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/09\/Brigade-Enterprises-Limited.webp?resize=700%2C400&ssl=1 2x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/380717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=380717"}],"version-history":[{"count":3,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/380717\/revisions"}],"predecessor-version":[{"id":380733,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/380717\/revisions\/380733"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/380732"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=380717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=380717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=380717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}